Our Approach to ESG
Sight Sciences® is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. We plan to report our ESG activities and results as evidence of our commitment to what we believe is important to our customers, patients, employees, suppliers, and investors.
Our ESG strategy is grounded in business sustainability, our values, and our Code of Ethics and Conduct. We are committed to diversity, equity, inclusion and belonging in hiring and developing our talent, which we believe is critical to our future growth and success. We are proud of the cumulative impact we have had on the patients with over 200,000 total procedures performed with our surgical glaucoma and dry eye technologies. We are committed to research and development to stay at the forefront of ophthalmology treatments and elevate the standard of care for patients worldwide. We look forward to continuing to expand our ESG program while also helping thousands of patients every year.
Sight Sciences® has ISS prime status as of the August 18,2024 review.
EEO
At Sight Sciences, we believe that diverse, inclusive teams produce better insight, better solutions, and ultimately the best outcomes for patients. We are focused on a firm that is representative of the communities in which we operate. Sight Sciences annually submits to the United States Equal Employment Opportunity Commission (“EEOC”) an Employer Information Report (“EEO-1”) to provide data regarding the gender and racial/ethnic diversity of our colleagues in the United States. You can download below a PDF of data submitted to the EEOC for our 2021 EEO-1.